Literature DB >> 12724820

[Thalidomide: new perspectives for its use as antiinflammatory, immunossupressive and antiangiogenic drug].

Larissa de Godoy Borges1, Pedro Eduardo Frõehlich.   

Abstract

The new uses of thalidomide are reviewed. It has recently been used as antinflammatory, immunosuppressive, antiangiogenic, and antiviral agent. Although its mechanism of action is not yet understood, the advantage of its use in several diseases, such as erythema nodosum leprosum, multiple myeloma, and graft-versus-host-disease is evident. Owing to its teratogenic properties, the use of thalidomide must be very well controlled. However, thalidomide has become a very important alternative, with new applications being studied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724820     DOI: 10.1590/s0104-42302003000100041

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  2 in total

Review 1.  Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach.

Authors:  Priscila Longhin Bosquesi; Thais Regina Ferreira Melo; Ednir Oliveira Vizioli; Jean Leandro Dos Santos; Man Chin Chung
Journal:  Pharmaceuticals (Basel)       Date:  2011-10-27

2.  Thalidomide in plasma cell balanitis refractory to conventional topical treatment.

Authors:  Lucas Mariano Serrão; Karina Demoner de Abreu Sarmenghi; Barbara Christina Bonino Pereira Pinto; Paulo Bittencourt de Miranda
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.